ANATOMICAL THERAPEUTIC CHEMICAL (ATC) CLASSIFICATION SYSTEM |
|||||||||||||||
[WHO Collaborating Centre for Drug Statistics Methodology (WHOCC)] |
|||||||||||||||
|
|||||||||||||||
|
L |
|
|||||||||||||
|
L | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | Show WHO |
L01 | ANTINEOPLASTIC AGENTS | Show WHO |
L01A | ALKYLATING AGENTS | Show WHO |
L01AA | Nitrogen mustard analogues | Show WHO |
L01AA01 | Cyclophosphamide | Show WHO |
L01AA02 | Chlorambucil | Show WHO |
L01AA03 | Melphalan | Show WHO |
L01AA05 | Chlormethine | Show WHO |
L01AA06 | Ifosfamide | Show WHO |
L01AA07 | Trofosfamide | Show WHO |
L01AA08 | Prednimustine | Show WHO |
L01AB | Alkyl sulfonates | Show WHO |
L01AB01 | Busulfan | Show WHO |
L01AB02 | Treosulfan | Show WHO |
L01AB03 | Mannosulfan | Show WHO |
L01AC | Ethylene imines | Show WHO |
L01AC01 | Thiotepa | Show WHO |
L01AC02 | Triaziquone | Show WHO |
L01AC03 | Carboquone | Show WHO |
L01AD | Nitrosoureas | Show WHO |
L01AD01 | Carmustine | Show WHO |
L01AD02 | Lomustine | Show WHO |
L01AD03 | Semustine | Show WHO |
L01AD04 | Streptozocin | Show WHO |
L01AD05 | Fotemustine | Show WHO |
L01AD06 | Nimustine | Show WHO |
L01AD07 | Ranimustine | Show WHO |
L01AG | Epoxides | Show WHO |
L01AG01 | Etoglucid | Show WHO |
L01AX | Other alkylating agents | Show WHO |
L01AX01 | Mitobronitol | Show WHO |
L01AX02 | Pipobroman | Show WHO |
L01AX03 | Temozolomide | Show WHO |
L01AX04 | Dacarbazine | Show WHO |
L01B | ANTIMETABOLITES | Show WHO |
L01BA | Folic acid analogues | Show WHO |
L01BA01 | Methotrexate | Show WHO |
L01BA03 | Raltitrexed | Show WHO |
L01BA04 | Pemetrexed | Show WHO |
L01BB | Purine analogues | Show WHO |
L01BB02 | Mercaptopurine | Show WHO |
L01BB03 | Tioguanine | Show WHO |
L01BB04 | Cladribine | Show WHO |
L01BB05 | Fludarabine | Show WHO |
L01BC | Pyrimidine analogues | Show WHO |
L01BC01 | Cytarabine | Show WHO |
L01BC02 | Fluorouracil | Show WHO |
L01BC03 | Tegafur | Show WHO |
L01BC04 | Carmofur | Show WHO |
L01BC05 | Gemcitabine | Show WHO |
L01BC06 | Capecitabine | Show WHO |
L01BC07 | azacitidine | Show WHO |
L01BC08 | decitabine | Show WHO |
L01BC52 | Fluorouracil, combinations | Show WHO |
L01BC53 | Tegafur, combinations | Show WHO |
L01C | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | Show WHO |
L01CA | Vinca alkaloids and analogues | Show WHO |
L01CA01 | Vinblastine | Show WHO |
L01CA02 | Vincristine | Show WHO |
L01CA03 | Vindesine | Show WHO |
L01CA04 | Vinorelbine | Show WHO |
L01CB | Podophyllotoxin derivatives | Show WHO |
L01CB01 | Etoposide | Show WHO |
L01CB02 | Teniposide | Show WHO |
L01CC | Colchicine derivatives | Show WHO |
L01CC01 | Demecolcine | Show WHO |
L01CD | Taxanes | Show WHO |
L01CD01 | Paclitaxel | Show WHO |
L01CD02 | Docetaxel | Show WHO |
L01CX | Other plant alkaloids and natural products | Show WHO |
L01CX01 | Trabectedin | Show WHO |
L01D | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES | Show WHO |
L01DA | Actinomycines | Show WHO |
L01DA01 | Dactinomycin | Show WHO |
L01DB | Anthracyclines and related substances | Show WHO |
L01DB01 | Doxorubicin | Show WHO |
L01DB02 | Daunorubicin | Show WHO |
L01DB03 | Epirubicin | Show WHO |
L01DB04 | Aclarubicin | Show WHO |
L01DB05 | Zorubicin | Show WHO |
L01DB06 | Idarubicin | Show WHO |
L01DB07 | Mitoxantrone | Show WHO |
L01DB08 | Pirarubicin | Show WHO |
L01DB09 | Valrubicin | Show WHO |
L01DC | Other cytotoxic antibiotics | Show WHO |
L01DC01 | Bleomycin | Show WHO |
L01DC02 | Plicamycin | Show WHO |
L01DC03 | Mitomycin | Show WHO |
L01DC04 | ixabepilone | Show WHO |
L01X | OTHER ANTINEOPLASTIC AGENTS | Show WHO |
L01XA | Platinum compounds | Show WHO |
L01XA01 | Cisplatin | Show WHO |
L01XA02 | Carboplatin | Show WHO |
L01XA03 | Oxaliplatin | Show WHO |
L01XB | Methylhydrazines | Show WHO |
L01XB01 | Procarbazine | Show WHO |
L01XC | Monoclonal antibodies | Show WHO |
L01XC01 | Edrecolomab | Show WHO |
L01XC02 | Rituximab | Show WHO |
L01XC03 | Trastuzumab | Show WHO |
L01XC04 | Alemtuzumab | Show WHO |
L01XC05 | Gemtuzumab | Show WHO |
L01XC06 | cetuximab | Show WHO |
L01XC07 | bevacizumab | Show WHO |
L01XC08 | panitumumab | Show WHO |
L01XC09 | catumaxomab | Show WHO |
L01XC10 | ofatumumab | Show WHO |
L01XD | Agents used in photodynamic therapy | Show WHO |
L01XD01 | Porfimer sodium | Show WHO |
L01XD02 | Verteporfin | Show WHO |
L01XD03 | Methyl aminolevulinate | Show WHO |
L01XD04 | Aminolevulinic acid | Show WHO |
L01XD05 | temoporfin | Show WHO |
L01XD06 | efaproxiral | Show WHO |
L01XE | Protein kinase inhibitors | Show WHO |
L01XE01 | Imatinib | Show WHO |
L01XE02 | Gefitnib | Show WHO |
L01XE03 | Erlotinib | Show WHO |
L01XE04 | Sunitinib | Show WHO |
L01XE05 | Sorafenib | Show WHO |
L01XE06 | Dasatinib | Show WHO |
L01XE07 | Lapatinib | Show WHO |
L01XE08 | Nilotinib | Show WHO |
L01XE09 | temsirolimus | Show WHO |
L01XE10 | everolimus | Show WHO |
L01XE11 | pazopanib | Show WHO |
L01XX | Other antineoplastic agents | Show WHO |
L01XX01 | Amsacrine | Show WHO |
L01XX02 | Asparaginase | Show WHO |
L01XX03 | Altretamine | Show WHO |
L01XX05 | Hydroxycarbamide | Show WHO |
L01XX07 | Lonidamine | Show WHO |
L01XX08 | Pentostatin | Show WHO |
L01XX09 | Miltefosine | Show WHO |
L01XX10 | Masoprocol | Show WHO |
L01XX11 | Estramustine | Show WHO |
L01XX14 | Tretinoin | Show WHO |
L01XX16 | Mitoguazone | Show WHO |
L01XX17 | Topotecan | Show WHO |
L01XX18 | Tiazofurine | Show WHO |
L01XX19 | Irinotecan | Show WHO |
L01XX22 | Alitretinoin | Show WHO |
L01XX23 | Mitotane | Show WHO |
L01XX24 | Pegaspargase | Show WHO |
L01XX25 | Bexarotene | Show WHO |
L01XX27 | Arsenic trioxide | Show WHO |
L01XX28 | Imatinib | Show WHO |
L01XX29 | Denileukin diftitox | Show WHO |
L01XX31 | Gefitinib | Show WHO |
L01XX32 | Bortezomib | Show WHO |
L01XX33 | Celecoxib | Show WHO |
L01XY | Combinations of antineoplastic agents | Show WHO |
L02 | ENDOCRINE THERAPY | Show WHO |
L02A | HORMONES AND RELATED AGENTS | Show WHO |
L02AA | Estrogens | Show WHO |
L02AA01 | Diethylstilbestrol | Show WHO |
L02AA02 | Polyestradiol phosphate | Show WHO |
L02AA03 | Ethinylestradiol | Show WHO |
L02AA04 | Fosfestrol | Show WHO |
L02AB | Progestogens | Show WHO |
L02AB01 | Megestrol | Show WHO |
L02AB02 | Medroxyprogesterone | Show WHO |
L02AB03 | Gestonorone | Show WHO |
L02AE | Gonadotropin releasing hormone analogues | Show WHO |
L02AE01 | Buserelin | Show WHO |
L02AE02 | Leuprorelin | Show WHO |
L02AE03 | Goserelin | Show WHO |
L02AE04 | Triptorelin | Show WHO |
L02AX | Other hormones | Show WHO |
L02B | HORMONE ANTAGONISTS AND RELATED AGENTS | Show WHO |
L02BA | Anti-estrogens | Show WHO |
L02BA01 | Tamoxifen | Show WHO |
L02BA02 | Toremifene | Show WHO |
L02BA03 | Fulvestrant | Show WHO |
L02BB | Anti-androgens | Show WHO |
L02BB01 | Flutamide | Show WHO |
L02BB02 | Nilutamide | Show WHO |
L02BB03 | Bicalutamide | Show WHO |
L02BG | Enzyme inhibitors | Show WHO |
L02BG01 | Aminogluthetimide | Show WHO |
L02BG02 | Formestane | Show WHO |
L02BG03 | Anastrozole | Show WHO |
L02BG04 | Letrozole | Show WHO |
L02BG05 | Vorozole | Show WHO |
L02BG06 | Exemestane | Show WHO |
L03 | IMMUNOSTIMULANTS | Show WHO |
L03A | CYTOKINES AND IMMUNOMODULATORS | Show WHO |
L03AA | Colony stimulating factors | Show WHO |
L03AA02 | Filgrastim | Show WHO |
L03AA03 | Molgramostim | Show WHO |
L03AA09 | Sargramostim | Show WHO |
L03AA10 | Lenograstim | Show WHO |
L03AA12 | Ancestim | Show WHO |
L03AA13 | Pegfilgrastim | Show WHO |
L03AB | Interferons | Show WHO |
L03AB01 | Interferon alfa natural | Show WHO |
L03AB02 | Interferon beta natural | Show WHO |
L03AB03 | Interferon gamma | Show WHO |
L03AB04 | Interferon alfa-2a | Show WHO |
L03AB05 | Interferon alfa-2b | Show WHO |
L03AB06 | Interferon alfa-n1 | Show WHO |
L03AB07 | Interferon beta-1a | Show WHO |
L03AB08 | Interferon beta-1b | Show WHO |
L03AB09 | Interferon alfacon-1 | Show WHO |
L03AB10 | Peginterferon alfa-2b | Show WHO |
L03AB11 | Peginterferon alfa-2a | Show WHO |
L03AC | Interleukins | Show WHO |
L03AC01 | Aldesleukin | Show WHO |
L03AC02 | Oprelvekin | Show WHO |
L03AX | Other cytokines and immunomodulators | Show WHO |
L03AX01 | Lentinan | Show WHO |
L03AX02 | Roquinimex | Show WHO |
L03AX03 | BCG vaccine | Show WHO |
L03AX04 | Pegademase | Show WHO |
L03AX05 | Pidotimod | Show WHO |
L03AX07 | Poly I:C | Show WHO |
L03AX08 | Poly ICLC | Show WHO |
L03AX09 | Thymopentin | Show WHO |
L03AX10 | Immunocyanin | Show WHO |
L03AX11 | Tasonermin | Show WHO |
L03AX12 | Melanoma vaccine | Show WHO |
L03AX13 | Glatiramer acetate | Show WHO |
L04 | IMMUNOSUPPRESSIVE AGENTS | Show WHO |
L04A | IMMUNOSUPPRESSIVE AGENTS | Show WHO |
L04AA | Selective immunosuppressive agents | Show WHO |
L04AA01 | Ciclosporin | Show WHO |
L04AA02 | Muromonab-CD3 | Show WHO |
L04AA03 | Antilymphocyte immunoglobulin (horse) | Show WHO |
L04AA04 | Antithymocyte immunoglobulin (rabbit) | Show WHO |
L04AA05 | Tacrolimus | Show WHO |
L04AA06 | Mycophenolic acid | Show WHO |
L04AA08 | Daclizumab | Show WHO |
L04AA09 | Basiliximab | Show WHO |
L04AA10 | Sirolimus | Show WHO |
L04AA11 | Etanercept | Show WHO |
L04AA12 | Infliximab | Show WHO |
L04AA13 | Leflunomide | Show WHO |
L04AA14 | Anakinra | Show WHO |
L04AA15 | Alefacept | Show WHO |
L04AA16 | Afelimomab | Show WHO |
L04AA17 | Adalimumab | Show WHO |
L04AA18 | Everolimus | Show WHO |
L04AA19 | Gusperimus | Show WHO |
L04AA21 | Efalizumab | Show WHO |
L04AB | Tumor necrosis factor alpha (TNF-ес) inhibitors | Show WHO |
L04AB01 | Etanercept | Show WHO |
L04AB02 | Infliximab | Show WHO |
L04AB03 | Afelimomab | Show WHO |
L04AB04 | Adalimumab | Show WHO |
L04AB05 | Certolizumab pegol | Show WHO |
L04AC | Interleukin inhibitors | Show WHO |
L04AC01 | Daclizumab | Show WHO |
L04AC02 | Basiliximab | Show WHO |
L04AC03 | Anakinra | Show WHO |
L04AD | Calcineurin inhibitors | Show WHO |
L04AD01 | Ciclosporin | Show WHO |
L04AD02 | Tacrolimus | Show WHO |
L04AX | Other immunosuppressive agents | Show WHO |
L04AX01 | Azathioprine | Show WHO |
L04AX02 | Thalidomide | Show WHO |
L04AX03 | Methotrexate | Show WHO |
|
|||||||||||||||
|
L |
|
|||||||||||||
|